9 results on '"de Longueville D"'
Search Results
2. Nasopharyngeal cooling during resuscitation: randomized study
- Author
-
Taccone, F, primary, Eichwede, F, additional, Desruelles, D, additional, De Longueville, D, additional, Busch, HJ, additional, and Barbut, D, additional
- Published
- 2009
- Full Text
- View/download PDF
3. 247 Effets de l’installation d’un accueil de première ligne médicalisé à l’entrée d’un service d’urgence sur les délais de prise en charge des patients et sur les cas d’agressivité rencontrés dans le service. Comparaison à une période sans APL-M
- Author
-
Devriendt, V., primary, De Villenfagne, M.A., additional, De Longueville, D., additional, Paquay, O., additional, Caussade, S., additional, Van Loo, Ch., additional, Kirkove, P., additional, and Mols, P., additional
- Published
- 2004
- Full Text
- View/download PDF
4. Utilisation du Lucas ® dans l'arrêt cardiorespiratoire dans un SMUR et au niveau du service des urgences. Étude de faisabilité
- Author
-
Claessens, B., Lagneaux, A., Kirsch, L., de Longueville, D., Taymans, L., Decroly, M., and Mols, P.
- Published
- 2007
- Full Text
- View/download PDF
5. Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial
- Author
-
Pierre-Marie Roy, Raphaëlle Lopez, Mustapha Sebbane, Charlotte Steinier, Benjamin Planquette, Nicolas Falvo, Tali-Anne Szwebel, Olivier Hugli, Ygal Benhamou, Jeannot Schmidt, Nicolas Dublanchet, Magali Bartiaux, Alexandre Ghuysen, Delphine Douillet, Antoine Elias, Luc-Marie Joly, Isabelle Mahé, Nicolas Javaud, Laura M. Faber, Francis Couturaud, Isabelle Quéré, Jerome Bokobza, Karine Montaclair, Menno V. Huisman, Damien Viglino, Rosen Cren, Armelle Arnoux, Andrea Penaloza, Gilles Chatellier, Frits I. Mulder, Henry Juchet, Stephan V. Hendriks, Frederikus A. Klok, François-Xavier Lapébie, Thomas Moumneh, Marie Daoud-Elias, Guy Meyer, Gilles Pernod, David Jiménez, Olivier Sanchez, Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM), MitoVasc - Physiopathologie Cardiovasculaire et Mitochondriale (MITOVASC), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), SFR UA 4208 Interactions Cellulaires et Applications Thérapeutiques (ICAT), Université d'Angers (UA), F-Crin Innovte [CHU Saint-Etienne], Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] (CHU ST-E), F-CRIN, Innovative clinical research network in vaccinology (I-REIVAC), Université Catholique de Louvain = Catholic University of Louvain (UCL), Cliniques Universitaires Saint-Luc [Bruxelles], Lausanne University Hospital, Leiden University Medical Center (LUMC), Universiteit Leiden, CIC - HEGP (CIC 1418), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Centre Hospitalier Intercommunal Toulon-La Seyne sur Mer - Hôpital Sainte-Musse, Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO), Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO), CIC Brest, Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital de la Cavale Blanche, Services des urgences [CHU Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU), University Hospital Sart Tilman [Liège, Belgium], Rode Kruis Hospital Beverwijk, Innovations thérapeutiques en hémostase = Innovative Therapies in Haemostasis (IThEM - U1140), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), AP-HP - Hôpital Cochin Broca Hôtel Dieu [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hypoxie et PhysioPathologie (HP2), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Grenoble Alpes (UGA), CHU Grenoble, Pôle Urgences [CHU Clermont-Ferrand], CHU Gabriel Montpied [Clermont-Ferrand], CHU Clermont-Ferrand-CHU Clermont-Ferrand, Université Clermont Auvergne (UCA), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Hôpital Louis Mourier - AP-HP [Colombes], Hôpital Saint-Pierre, Bruxelles, CHU Montpellier, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Caractéristiques féminines des dysfonctions des interfaces cardio-vasculaires (EA 2992), Université Montpellier 1 (UM1)-Université de Montpellier (UM), CIC Montpellier, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Hôpital Saint Eloi (CHRU Montpellier), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Dijon, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Centre Hospitalier Le Mans (CH Le Mans), Hôpital Charles Nicolle [Rouen], Normandie Université (NU)-Normandie Université (NU), Endothélium, valvulopathies et insuffisance cardiaque (EnVI), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital Cochin [AP-HP], Translational Innovation in Medicine and Complexity / Recherche Translationnelle et Innovation en Médecine et Complexité - UMR 5525 (TIMC ), VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes (UGA)-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP ), Université Grenoble Alpes (UGA), Techniques pour l'Evaluation et la Modélisation des Actions de la Santé (TIMC-ThEMAS ), Université Grenoble Alpes (UGA)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes (UGA)-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP ), CHU Clermont-Ferrand, Hôpital Lapeyronie [Montpellier] (CHU), Université de Montpellier (UM), Universidad de Alcalá de Henares (UAH), Graduate School, Vascular Medicine, ACS - Pulmonary hypertension & thrombosis, ARD - Amsterdam Reproduction and Development, HOME-PE Study Group, Feral, A.L., Pastré, J., Roche, A., Cornand, D., Martinez, P., Poggi, J.N., Rezkallah, S., Belizna, C., Bigou, Y., Carraro, Q., Friou, E., Gourdier, A.S., Palous, C., Goetghebeur, D., Armengol, G., Tzebia, C., Dumas, F., Maignan, M., Moustafa, F., Charpentier, S., Bura-Rivière, A., Maillet, F., Plaisance, L., Galanaud, J.P., Henneton, P., Jreige, R., Lehodey, B., Honnart, D., Tfifha, R., Schotte, T., Al Dandachi, G., Simoneau, G., Le Coat, A., Casarin, C., Cismas, A., Germeau, B., Grégoire, C., Hainaut, P., Hermans, C., Lambert, C., Steenebrugge, F., Muriel, M., Moonen, S., Gabrovska, M., Kreps, B., de Longueville, D., Mols, P., Delvaux, P., Van Nuffelen, M., Motte, S., Kamphuisen, P.W., Bresser, C., Hendriks, S., Mairuhu, ATA, van der Pol, L., Fogteloo, A.J., Nijkeuter, M., de Winter, M., Chatellier, G., Hugli, O., Huisman, M., Jimenez, D., Klok, F.A., Meyer, G., Penaloza, A., Roy, P.M., Sanchez, O., Girard, P., den Exter, P., Parent, F., Aujesky, D., Bounameaux, H., Laporte, S., Ten Cate, H., Gable, B., Augereau, C., Chrétien, J.M., Goraguer, A., Houssin, E., Leconte, L., Smii, S., Lasri, F., Haton, C., Marquette, A., Mercier, M., Abello, M., Mitri, F., Leclerq, C., Giansily, D., Aubert, C., Ragueneau, C., Baty, N., Veillon, A.S., Le Gall, B., Bulte, C., Pontdemé, G., Chibah, A., Atia, Y., Makele, P.M., Bouchafa, F., Camminada, C., Hebrard, M., Pelvet, B., Baudoin, D., Pinson, M., Helfer, H., Lefebvre, S., Pontal, D., Lextreyt, B., Bernard, C., Robert, A., Pichon, I., Beuvard, E., Dekeister, A.C., Leon, C., Gerhard-Donnet, H., Moll, S., and de Bruijn, M.
- Subjects
medicine.medical_specialty ,Randomization ,Cardiologie et circulation ,Population ,Severity of Illness Index ,[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract ,law.invention ,Randomized controlled trial ,Clinical Research ,law ,medicine ,Humans ,AcademicSubjects/MED00200 ,education ,Risk assessment ,education.field_of_study ,Intention-to-treat analysis ,business.industry ,Emergency department ,Acute Disease ,Patient Discharge ,Prognosis ,Pulmonary Embolism/drug therapy ,Risk Assessment ,Clinical decision-making ,Home treatment ,Pulmonary embolism ,Absolute risk reduction ,medicine.disease ,Hospitals ,Thrombosis and Antithrombotic Treatment ,Hospitalization ,Embolism ,Emergency medicine ,Cardiology and Cardiovascular Medicine ,business - Abstract
AIMS: The aim of this study is to compare the Hestia rule vs. the simplified Pulmonary Embolism Severity Index (sPESI) for triaging patients with acute pulmonary embolism (PE) for home treatment. METHODS AND RESULTS: Normotensive patients with PE of 26 hospitals from France, Belgium, the Netherlands, and Switzerland were randomized to either triaging with Hestia or sPESI. They were designated for home treatment if the triaging tool was negative and if the physician-in-charge, taking into account the patient's opinion, did not consider that hospitalization was required. The main outcomes were the 30-day composite of recurrent venous thrombo-embolism, major bleeding or all-cause death (non-inferiority analysis with 2.5% absolute risk difference as margin), and the rate of patients discharged home within 24 h after randomization (NCT02811237). From January 2017 through July 2019, 1975 patients were included. In the per-protocol population, the primary outcome occurred in 3.82% (34/891) in the Hestia arm and 3.57% (32/896) in the sPESI arm (P = 0.004 for non-inferiority). In the intention-to-treat population, 38.4% of the Hestia patients (378/984) were treated at home vs. 36.6% (361/986) of the sPESI patients (P = 0.41 for superiority), with a 30-day composite outcome rate of 1.33% (5/375) and 1.11% (4/359), respectively. No recurrent or fatal PE occurred in either home treatment arm. CONCLUSIONS: For triaging PE patients, the strategy based on the Hestia rule and the strategy based on sPESI had similar safety and effectiveness. With either tool complemented by the overruling of the physician-in-charge, more than a third of patients were treated at home with a low incidence of complications., SCOPUS: ar.j, info:eu-repo/semantics/published
- Published
- 2021
- Full Text
- View/download PDF
6. [Out-of-hospital cardiac arrests : year 2023 review of the CHC - Bcar registry in Liege area (Belgium)].
- Author
-
Goffin P, Yerna M, Kinon G, Aouchria S, and de Longueville D
- Subjects
- Humans, Belgium epidemiology, Male, Female, Middle Aged, Aged, Emergency Medical Services, Aged, 80 and over, Adult, Electric Countershock, Out-of-Hospital Cardiac Arrest therapy, Registries, Cardiopulmonary Resuscitation methods
- Abstract
Out-of-hospital cardiac arrests represent impactful events. Despite the evolution of care, they are still associated with high morbidity and mortality. We present the analysis of our activity included in the 2023 CHC - Bcar registry in Liege area (Belgium). A cardiac massage is initiated by bystander in more than 50 % of cases. However, we must remember the crucial aspect of early resuscitation and defibrillation to improve outcome, just like the training of the general public in life-saving actions.
- Published
- 2025
7. A retrospective comparison of mechanical cardio-pulmonary ventilation and manual bag valve ventilation in non-traumatic out-of-hospital cardiac arrests: A study from the Belgian cardiac arrest registry.
- Author
-
Malinverni S, Wilmin S, de Longueville D, Sarnelli M, Vermeulen G, Kaabour M, Van Nuffelen M, Hubloue I, Scheyltjens S, Manara A, Mols P, Richard JC, and Desmet F
- Subjects
- Humans, Male, Female, Belgium epidemiology, Retrospective Studies, Aged, Middle Aged, Return of Spontaneous Circulation, Out-of-Hospital Cardiac Arrest therapy, Out-of-Hospital Cardiac Arrest mortality, Registries, Cardiopulmonary Resuscitation methods, Respiration, Artificial methods
- Abstract
Background: The optimal ventilation modalities to manage out-of-hospital cardiac arrest (OHCA) remain debated. A specific pressure mode called cardio-pulmonary ventilation (CPV) may be used instead of manual bag ventilation (MBV). We sought to analyse the association between mechanical CPV and return of spontaneous circulation (ROSC) in non-traumatic OHCA., Methods: MBV and CPV were retrospectively identified in patients with non-traumatic OHCA from the Belgian Cardiac Arrest Registry. We used a two-level mixed-effects multivariable logistic regression analysis to determine the association between the ventilation modalities and outcomes. The primary and secondary study criteria were ROSC and survival with a Cerebral Performance Category (CPC) score of 1 or 2 at 30 days. Age, sex, initial rhythm, no-flow duration, low-flow duration, OHCA location, use of a mechanical chest compression device and Rankin status before arrest were used as covariables., Results: Between January 2017 and December 2021, 2566 patients with OHCA who fulfilled the inclusion criteria were included. 298 (11.6%) patients were mechanically ventilated with CPV whereas 2268 were manually ventilated. The use of CPV was associated with greater probability of ROSC both in the unadjusted (odds ratio: 1.28, 95% confidence interval [CI]: 1.01-1.63; p = 0.043) and adjusted analyses (adjusted odds ratio [aOR]: 2.16, 95%CI 1.37-3.41; p = 0.001) but not with a lower CPC score (aOR: 1.44, 95%CI 0.72-2.89; p = 0.31)., Conclusions: Compared with MBV, CPV was associated with an increased risk of ROSC but not with improved an CPC score in patients with OHCA. Prospective randomised trials are needed to challenge these results., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: ‘Jean-Christophe Richard declares receiving a part time salary from Air Liquide Medical Systems (ALMS) as Scientific Director of the Med2 Lab in complement of the Angers University Hospital. Moreover, he declares patents from ALMS, GE and COVIDIEN. All other authors state that they have no financial or personal relationships with other people or organisations that could inappropriately influence their work.’., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
8. Postresuscitation oxygen reserve index-guided oxygen titration in out-of-hospital cardiac arrest survivors: A randomised controlled trial.
- Author
-
Malinverni S, Wilmin S, Stoll T, de Longueville D, Preseau T, Mohler A, Bouazza FZ, Annoni F, Gerard L, Denoel P, and Boutrika I
- Subjects
- Humans, Oxygen, Prospective Studies, Hypoxia complications, Survivors, Out-of-Hospital Cardiac Arrest therapy, Out-of-Hospital Cardiac Arrest complications, Hyperoxia etiology, Cardiopulmonary Resuscitation methods
- Abstract
Background and Purpose: Hyperoxia after return of spontaneous circulation is potentially harmful, and oxygen titration in a prehospital setting is challenging. This study aimed to compare outcomes of oxygen reserve index-supported prehospital oxygen titration during prehospital transport with those of standard oxygen titration., Methods and Trial Design: We enrolled patients who experienced return of spontaneous circulation after cardiac arrest in a prospective randomized study. Patients were randomly divided (1:1) to undergo oxygen titration based on the oxygen reserve index and SpO
2 (intervention) or SpO2 only (control). FI O2 titration targeted SpO2 level maintenance at 94-98%. The primary outcome was the normoxia index, reflecting the proportion of both hyperoxia- and hypoxia-free time during prehospital intervention., Results: A total of 92 patients were included in the study. The mean normoxia index was 0.828 in the control group and 0.847 in the intervention group (difference = 0.019 [95 % CI, -0.056-0.095]), with no significant difference between the groups. No significant differences were found in the incidence of hypoxia or hyperoxia between groups. No difference was found in the mean PaO2 at hospital admission (116 mmHg [IQR: 89-168 mmHg] in the control group vs 115 mmHg [IQR: 89-195 mmHg] in the intervention group; p = 0.86). No difference was observed in serum neuron-specific enolase levels 48 h post-ROSC after adjustment for known confounders., Conclusion: Oxygen reserve index- combined with pulse oximetry-based prehospital oxygen titration did not significantly improve the normoxia index compared with standard oxygen titration based on pulse oximetry alone (NCT03653325)., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Stefano Malinverni received all the consumable necessary for the study from Masimo Corporation. All the other authors stated that they have no financial and personal relationships with other people or organizations that could inappropriately influence their work., (Copyright © 2023 Elsevier B.V. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
9. Effect of Bag-Mask Ventilation vs Endotracheal Intubation During Cardiopulmonary Resuscitation on Neurological Outcome After Out-of-Hospital Cardiorespiratory Arrest: A Randomized Clinical Trial.
- Author
-
Jabre P, Penaloza A, Pinero D, Duchateau FX, Borron SW, Javaudin F, Richard O, de Longueville D, Bouilleau G, Devaud ML, Heidet M, Lejeune C, Fauroux S, Greingor JL, Manara A, Hubert JC, Guihard B, Vermylen O, Lievens P, Auffret Y, Maisondieu C, Huet S, Claessens B, Lapostolle F, Javaud N, Reuter PG, Baker E, Vicaut E, and Adnet F
- Subjects
- Aged, Belgium, Emergency Medical Services, Female, France, Humans, Intention to Treat Analysis, Male, Middle Aged, Nervous System Diseases etiology, Out-of-Hospital Cardiac Arrest complications, Out-of-Hospital Cardiac Arrest mortality, Advanced Cardiac Life Support methods, Intubation, Intratracheal, Laryngeal Masks, Out-of-Hospital Cardiac Arrest therapy
- Abstract
Importance: Bag-mask ventilation (BMV) is a less complex technique than endotracheal intubation (ETI) for airway management during the advanced cardiac life support phase of cardiopulmonary resuscitation of patients with out-of-hospital cardiorespiratory arrest. It has been reported as superior in terms of survival., Objectives: To assess noninferiority of BMV vs ETI for advanced airway management with regard to survival with favorable neurological function at day 28., Design, Settings, and Participants: Multicenter randomized clinical trial comparing BMV with ETI in 2043 patients with out-of-hospital cardiorespiratory arrest in France and Belgium. Enrollment occurred from March 9, 2015, to January 2, 2017, and follow-up ended January 26, 2017., Intervention: Participants were randomized to initial airway management with BMV (n = 1020) or ETI (n = 1023)., Main Outcomes and Measures: The primary outcome was favorable neurological outcome at 28 days defined as cerebral performance category 1 or 2. A noninferiority margin of 1% was chosen. Secondary end points included rate of survival to hospital admission, rate of survival at day 28, rate of return of spontaneous circulation, and ETI and BMV difficulty or failure., Results: Among 2043 patients who were randomized (mean age, 64.7 years; 665 women [32%]), 2040 (99.8%) completed the trial. In the intention-to-treat population, favorable functional survival at day 28 was 44 of 1018 patients (4.3%) in the BMV group and 43 of 1022 patients (4.2%) in the ETI group (difference, 0.11% [1-sided 97.5% CI, -1.64% to infinity]; P for noninferiority = .11). Survival to hospital admission (294/1018 [28.9%] in the BMV group vs 333/1022 [32.6%] in the ETI group; difference, -3.7% [95% CI, -7.7% to 0.3%]) and global survival at day 28 (55/1018 [5.4%] in the BMV group vs 54/1022 [5.3%] in the ETI group; difference, 0.1% [95% CI, -1.8% to 2.1%]) were not significantly different. Complications included difficult airway management (186/1027 [18.1%] in the BMV group vs 134/996 [13.4%] in the ETI group; difference, 4.7% [95% CI, 1.5% to 7.9%]; P = .004), failure (69/1028 [6.7%] in the BMV group vs 21/996 [2.1%] in the ETI group; difference, 4.6% [95% CI, 2.8% to 6.4%]; P < .001), and regurgitation of gastric content (156/1027 [15.2%] in the BMV group vs 75/999 [7.5%] in the ETI group; difference, 7.7% [95% CI, 4.9% to 10.4%]; P < .001)., Conclusions and Relevance: Among patients with out-of-hospital cardiorespiratory arrest, the use of BMV compared with ETI failed to demonstrate noninferiority or inferiority for survival with favorable 28-day neurological function, an inconclusive result. A determination of equivalence or superiority between these techniques requires further research., Trial Registration: clinicaltrials.gov Identifier: NCT02327026.
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.